Up Oncolytics Inc

Promentis Pharmaceuticals, Inc. is a privately-held biopharmaceutical company based in Milwaukee, WI, dedicated to developing innovative therapies for neuropsychiatric disorders. With a focus on trichotillomania, a prevalent disorder lacking approved treatment options, the company aims to address the underlying pathology of this condition and other related obsessive-compulsive and addictive disorders through novel oral compounds that engage System xc-, a central nervous system target. Driven by a world-class leadership team and a growing roster of recognized leaders in the biopharmaceutical industry and clinical experts in CNS disorders, Promentis Pharmaceuticals is committed to redefining what is possible in the treatment of neuropsychiatric disorders, offering hope and potential breakthroughs for patients worldwide.Generated from the website

TCR Biotherapeutics LLC is a Milwaukee-based company that specializes in harnessing the power of immunobiology to develop innovative therapies for severe autoimmune diseases. Their novel approach focuses on achieving immunomodulatory effects and restoring balance to the immune system, offering off-the-shelf treatments with multiple therapeutic applications. With a targeted approach to immunosuppression and more specific inhibition of immune activation, TCR Biotherapeutics aims to address the source of autoimmune diseases, providing groundbreaking solutions for patients in need.Generated from the website

Cytegen Corp is a technology company based in Milwaukee, WI, specializing in innovative solutions for data management and analysis. With a focus on cutting-edge research and development, Cytegen Corp provides tailored software and services to help businesses optimize their operations and make data-driven decisions. Generated from their business information